Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Defect in Ikaros gene mimics human B cell leukemia

10.02.2014
Meinrad Busslinger and his team from the Institute of Molecular Pathology (IMP) investigate the differentiation of stem cells to mature B cells.

They now present for the first time molecular details on the role of the Ikaros gene during early B cell development. A defect in Ikaros function causes an early block in B-lymphopoiesis and prevents the development of mature B cells.


Cross-section through the bone marrow of a mouse lacking the Ikaros Protein

The cells stay in an aberrant state, which closely resembles that of cells in B-ALL, a special form of human B cell leukemia. The results of this study are published in the current Advance Online edition of Nature Immunology (doi; 10.1038/ni.2828).

The immune system consists of a complex structure of organs, cell types and cell-cell interactions which protects the organism from harmful intruders as well as aberrant cells within the body. Two mechanisms of immunological defense can be distinguished – innate and adaptive immunity. Cells from the adaptive immune system recognize specific structures of invaders and develop defense mechanisms accordingly. B and T cells from the group of white blood cells represent the main players of the adaptive immune defense.

Role of Ikaros in B cells is no longer a myth

B cells are derived from blood stem cells in the bone marrow. By differentiating through several stages of lymphopoiesis, these stem cells give rise to fully functional, mature B cells. This process is tightly controlled by a group of regulatory proteins called transcription factors. “We already know several transcription factors that play a central role in B cell differentiation. Pax5 for example represents a critical factor which activates the B cell-specific program in precursor cells and simultaneously suppresses alternative cell fates”, Busslinger explains. ”For Ikaros we did not know until now what this factor is doing during early B cell development”.

The researchers from Busslinger’s team therefore analyzed mice specifically lacking Ikaros from an early stage of B cell development on. They found that Ikaros deficiency arrested B cell development in an aberrant “pro-B” cell stage and prevented further differentiation. Without Ikaros, the cells were not able to transmit certain signals via their cell surface receptors. Furthermore, they showed increased cell adhesion and reduced migration compared to normal cells.

European grant allows comprehensive analyses

In 2011, Busslinger was awarded one of the prestigious „ERC Advanced Grants“ from the European Union. This generous financial support made it possible to tackle a large scope project - the systematic analysis of transcription factors in the immune system. Busslinger and his team use the technology of biotin-tagging to add a “molecular label” to transcription factors for their studies. This facilitates the isolation of these proteins from murine B cells. Despite the huge effort that comes with this method, Busslinger and his co-workers have already labelled and analysed about ten transcription factors using biotin-tagging. In most cases, they were successful with this approach. For Ikaros, this meant gaining fundamental new insights into the molecular way of action. The researchers identified a large number of genes that are controlled by this transcription factor during early B cell development.

Striking similarity to human tumor cells

The Ikaros gene is a so-called tumor-suppressor gene that protects cells from becoming tumorigenic under normal conditions. Loss of the function of this gene has been associated with the development of “B-ALL”, a certain form of human leukemia, which requires further genetic alterations in addition to the Ikaros gene mutation. As in mice with a mutated Ikaros gene, B cells from human B-ALL patients are arrested at an early checkpoint of B cell development.

Due to the striking similarity between the defect in the mouse model and human cancers, this study may help to understand how leukemia develops at the molecular level. In the future, the findings might be valuable in devising new concepts for the prevention or therapy of blood cancer.

Original Publication

TA Schwickert, H. Tagoh, S. Gültekin, A. Dakic, E. Axelsson, M. Minnich, A. Ebert, B. Werner, M. Roth, L. Cimmino, RA Dickins, J. Zuber, M. Jaritz and M. Busslinger. „Stage-specific control of early B cell development by the transcription factor Ikaros”, Nature Immunology 15, doi; 10.1038/ni.2828.

This work was funded by Boehringer Ingelheim, an ERC Grant from the EU, the Austrian Initiative GEN-AU of the Federal Ministry of Science and Research and an EMBO grant.

Illustration

An illustration can be downloaded from the IMP Website and used free of charge in connection with this press release: http://www.imp.ac.at/pressefoto-Ikaros

Caption: Cross-section through the bone marrow of a mouse lacking the Ikaros protein. In the absence of Ikaros, an important early checkpoint of B-lymphopoiesis is no longer functional. As a consequence, early B cell development is arrested at an aberrant “pro-B” cell stage. Staining of the sections visualizes the arrested pro-B cells (green), myeloid cells (red) and nuclei (blue). Copyright: IMP

About Meinrad Busslinger

Meinrad Busslinger was born in Switzerland in 1952. He studied Biochemistry at the ETH Zürich and obtained a doctorate in molecular biology from the University of Zürich. Following postdoctoral studies at the MRC Institute Mill Hill, London, he became a group leader at the University of Zürich. In 1987, he followed Max Birnstiel as a Senior Group Leader to the newly founded IMP in Vienna. Busslinger is Director of Academic Affairs at the IMP, and since 2013 also scientific Deputy Director of the institute.

Busslinger is Professor at the University of Vienna and a full member of the Austrian Academy of Sciences and of the European Molecular Biology Organisation. He has published over 160 papers in peer-reviewed journals and serves on editorial boards of several scientific journals. Busslinger was awarded the Wittgenstein prize of the Austrian Government in 2001 and the Virchow Medal by the University of Würzburg in 2010.

About the IMP

The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 30 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology.

Contact

Dr. Heidemarie Hurtl
Communications
IMP Research Institute of Molecular Pathology
Dr. Bohr-Gasse 7
A 1030 Vienna
Tel. +43 (0)1 79730-3625
E-mail: hurtl@imp.ac.at

Dr. Heidemarie Hurtl | idw
Further information:
http://www.imp.ac.at

More articles from Life Sciences:

nachricht Algorithms Offer Insight into Cellular Development
31.08.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Cancer: Molecularly shutting down cancer cachexia
31.08.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Virtual Reality: 3D Human Body Reconstruction from Fraunhofer HHI digitizes Human Beings

Scientists at the Fraunhofer Institute for Telecommunications, Heinrich Hertz Institute, HHI have developed a method by which the realistic image of a person can be transmitted into a virtual world. The 3D Human Body Reconstruction Technology captures real persons with multiple cameras at the same time and creates naturally moving dynamic 3D models. At this year’s trade fairs IFA in Berlin (Hall 11.1, Booth 3) and IBC in Amsterdam (Hall 8, Booth B80) Fraunhofer HHI will show this new technology.

Fraunhofer HHI researchers have developed a camera system that films people with a perfect three-dimensional impression. The core of this system is a stereo...

Im Focus: Streamlining accelerated computing for industry

PyFR code combines high accuracy with flexibility to resolve unsteady turbulence problems

Scientists and engineers striving to create the next machine-age marvel--whether it be a more aerodynamic rocket, a faster race car, or a higher-efficiency jet...

Im Focus: X-ray optics on a chip

Waveguides are widely used for filtering, confining, guiding, coupling or splitting beams of visible light. However, creating waveguides that could do the same for X-rays has posed tremendous challenges in fabrication, so they are still only in an early stage of development.

In the latest issue of Acta Crystallographica Section A: Foundations and Advances , Sarah Hoffmann-Urlaub and Tim Salditt report the fabrication and testing of...

Im Focus: Piggyback battery for microchips: TU Graz researchers develop new battery concept

Electrochemists at TU Graz have managed to use monocrystalline semiconductor silicon as an active storage electrode in lithium batteries. This enables an integrated power supply to be made for microchips with a rechargeable battery.

Small electrical gadgets, such as mobile phones, tablets or notebooks, are indispensable accompaniments of everyday life. Integrated circuits in the interiors...

Im Focus: UCI physicists confirm possible discovery of fifth force of nature

Light particle could be key to understanding dark matter in universe

Recent findings indicating the possible discovery of a previously unknown subatomic particle may be evidence of a fifth fundamental force of nature, according...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

The energy transition is not possible without Geotechnics

25.08.2016 | Event News

New Ideas for the Shipping Industry

24.08.2016 | Event News

A week of excellence: 22 of the world’s best computer scientists and mathematicians in Heidelberg

12.08.2016 | Event News

 
Latest News

Cancer: Molecularly shutting down cancer cachexia

31.08.2016 | Life Sciences

Robust fuel cell heating unit developed

31.08.2016 | Power and Electrical Engineering

Algorithms Offer Insight into Cellular Development

31.08.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>